Developer docs
API playgroundTry for free, no card

Search company profiles

Linepharma

Full company profile

uuid002vwr9

Namestring
Linepharma
Company typeenum
Private
Founded yearint
2015
Descriptiontext

Linepharma is referenced in the input data only through its associated domain, linepharma-lab.com. No verifiable information about the company's actual business, products, customers, technology, management, funding, or operating geographies is present in the supplied source material. Every structured field — including legal name, founded year, company type, domicile, headcount, revenue, funding rounds, products and services, partnerships, management team, and office locations — is empty or null. The sole observable data point is that linepharma-lab.com currently resolves to content from Heel Holland Zorgt (Heel Holland Zorgt), a Dutch lifestyle and fitness blog covering topics such as optimal training times, exercise motivation, sports nutrition, and home ventilation. The upstream source explicitly flags this content as unrelated to Linepharma, indicating a likely domain redirect, parking page, or content gap rather than a first-party corporate website. As a result, this description reflects the absence of evidence rather than any inference about Linepharma's underlying business; investors should treat Linepharma as a data-blind entity and conduct primary diligence (corporate registry searches, direct outreach, financial filings) before any commercial action.

Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersToronto, Canada
HQ citystring
Toronto
HQ countrystring
Canada
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
pharmaceutical products, drug manufacturing, medicinal products, pharmaceutical research, healthcare products
Industry2 codes
PRIMARYHLAGAHAL
HLAGAHAL
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/API & Small-Molecule Development/Manufacturing Services
SECONDARYHLAGAGAL
HLAGAGAL
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Biopharma Manufacturing Services (Biologics/Cell & Gene)
NAICS code1 code
  • 3254
SIC code1 code
  • 8731
Product category
Pharmaceuticals
No data
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

No Linepharma-specific offering details are present in the supplied source content. The source is from heelhollandzorgt.nl, a Dutch health/fitness blog unrelated to Linepharma. Based on the company name and URL "linepharma-lab.com," the entity appears to operate in the pharmaceutical/laboratory sector, but no products or services are documented in the input.

Differentiator
Functional benefit
Problem solved
No data
Market position
Customer concentration

Classification, Details

No data
Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Linepharma

Pharmaceuticalslinepharma-lab.com

What Linepharma does

Linepharma is referenced in the input data only through its associated domain, linepharma-lab.com. No verifiable information about the company's actual business, products, customers, technology, management, funding, or operating geographies is present in the supplied source material. Every structured field — including legal name, founded year, company type, domicile, headcount, revenue, funding rounds, products and services, partnerships, management team, and office locations — is empty or null. The sole observable data point is that linepharma-lab.com currently resolves to content from Heel Holland Zorgt (Heel Holland Zorgt), a Dutch lifestyle and fitness blog covering topics such as optimal training times, exercise motivation, sports nutrition, and home ventilation. The upstream source explicitly flags this content as unrelated to Linepharma, indicating a likely domain redirect, parking page, or content gap rather than a first-party corporate website. As a result, this description reflects the absence of evidence rather than any inference about Linepharma's underlying business; investors should treat Linepharma as a data-blind entity and conduct primary diligence (corporate registry searches, direct outreach, financial filings) before any commercial action.

Linepharma firmographics

Firmographics
Name
Linepharma
Website
https://linepharma-lab.com
Company type
Private
Founded year
2015
Headcount range
1–10 employees
Ownership category
akta.pro rank

Where Linepharma is headquartered

Location

Headquarters

HQ city
Toronto
HQ country
Canada
HQ region
North America

Markets served

Linepharma business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing

Linepharma product offering

Product offering

Core offering

No Linepharma-specific offering details are present in the supplied source content. The source is from heelhollandzorgt.nl, a Dutch health/fitness blog unrelated to Linepharma. Based on the company name and URL "linepharma-lab.com," the entity appears to operate in the pharmaceutical/laboratory sector, but no products or services are documented in the input.

Differentiator

Problem solved

Functional benefit

Linepharma technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Linepharma competitors and assessment

Company assessment

Market position

Customer concentration

Linepharma financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Linepharma leadership team

Management profile

Number of profiles

Linepharma funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Linepharma M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Linepharma

What does Linepharma do?

No Linepharma-specific offering details are present in the supplied source content. The source is from heelhollandzorgt.nl, a Dutch health/fitness blog unrelated to Linepharma. Based on the company name and URL "linepharma-lab.com," the entity appears to operate in the pharmaceutical/laboratory sector, but no products or services are documented in the input.

When was Linepharma founded?

Linepharma was founded in 2015. It employs 1 to 10 people.

Where is Linepharma based?

Linepharma is headquartered in Toronto, Canada, in the North America region.

Does Linepharma have an API?

No public API is recorded for Linepharma.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireLINEPHARMA INTERNATIONAL DÉPOSE UNE DEMANDE D'AUTORISATION DE FABRICATION ET DE MISE SUR LE MARCHÉ DE LA PILLULE ABORTIVE AU JAPONLinepharma International Ltd, a global leader in medical abortion, announced that its subsidiary Linepharma KK has filed for manufacturing and marketing authorization in Japan with the PMDA for its oral drug MEFEEGO™, a mifepristone and misoprostol combination for medical termination of pregnancy up to 63 days gestation. The filing is supported by a Japanese Phase III clinical trial involving 120 women aged 18 to 45, and if approved, it would become Japan's first authorized medical abortion drug, offering an alternative to the 156,430 surgical abortions performed in Japan in 2019 alone.PR NewswireLINEPHARMA INTERNATIONAL SOLICITA APROBACIÓN PARA FABRICACIÓN Y COMERCIALIZACIÓN DE SU PÍLDORA ABORTIVA EN JAPÓNLinepharma International Ltd. announced that its subsidiary, Linepharma KK, has applied for regulatory approval to manufacture and market the medical abortion drug MEFEEGO™ in Japan. If approved, this would mark the first time a medical abortion pill is authorized in the country, offering a new therapeutic option for Japanese women. The application is based on Phase III clinical trial results conducted locally with 120 participants.PR NewswireLINEPHARMA SOLICITA AUTORIZACIÓN DE FABRICACIÓN Y COMERCIALIZACIÓN DE LA PÍLDORA ABORTIVA EN JAPÓNLinepharma International Ltd., a global leader in medical abortion, announced through its subsidiary Linepharma KK that it has submitted a manufacturing and marketing authorization application to Japan's PMDA for MEFEEGO™, an oral mifepristone and misoprostol combination pill for medical termination of pregnancies up to 63 days. The application is based on Phase III clinical trial data from 120 women aged 18 to 45 in Japan. If approved, MEFEEGO™ would become Japan's first approved medication abortion drug, expanding beyond its current availability in 80 countries.PR NewswireLINEPHARMA INTERNATIONAL FILES FOR MANUFACTURING, MARKETING APPROVAL OF THE ABORTION PILL IN JAPANLinepharma International Ltd. announced that its subsidiary, Linepharma KK, has applied for manufacturing and marketing approval in Japan for MEFEEGO™, an oral drug for medical abortion. If approved by the Pharmaceuticals and Medical Devices Agency (PMDA), this would mark the first approved medical abortion drug in Japan, offering a new therapeutic option for Japanese women.